Several studies revealed an association between amino acid substitutions at the R70Q/H and L91M positions with disease progression to cirrhosis and HCC and a poor response to treatment with Peg-IFN and/or RBV [10,11,12,13,14,15,16,17]. The gene discussed is IFNA1; the disease is hepatocellular carcinoma.